Lucevida Pharmaceuticals Private Limited, a active private limited company, was established on 28 October 2014 in Siliguri, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51909WB2014PTC203886. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.41 M.
It upholds a compliant status. Employing 31 professional, Its leadership includes Abhijit Kundu (Director), Dibakar Paul (Director), Jhoni Kumar Roy (Director). Past directors included Abhijit Kundu, Jagonnath Sinha. It holds ₹1.30 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6 Buddha Deb Bose Road Ashrampara P.S. Siliguri, Siliguri, West Bengal, 734001.
U51909WB2014PTC203886
203886
28 October 2014
₹1.50 M
₹1.41 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Lucevida Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhijit Kundu | Director | 08 Feb 2020 | Current |
| Dibakar Paul | Director | 28 Oct 2014 | Current |
| Jhoni Kumar Roy | Director | 22 Apr 2022 | Current |
| Subrata Kundu | Director | 31 Jan 2015 | Current |
| Nitya Gopal Chakraborty | Director | 09 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 08 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lucevida Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 67.29% increase. The company also saw a substantial fall in profitability, with a 473.71% decrease in profit. The company's net worth Soared by an impressive increase of 217.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Lucevida Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹13,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2025 | State Bank Of India | ₹1.00 Cr | Open |
| 15 Sep 2020 | State Bank Of India | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Lucevida Pharmaceuticals has a workforce of 31 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lucevida Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucevida Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nitya Gopal Chakraborty was appointed as a Director was appointed as a Director on 09 Sep 2025 & has been associated with this company since 2 months 25 days . was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 10.00 M with Charge ID 101026517 was registered on 04 Jan 2025. was documented.
Progress on Lucevida Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Lucevida Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Progress on A charge with State Bank Of India of Rs. 3.00 M registered on 15 Sep 2020 with Charge ID 100375685 was modified on 02 Jun 2022. was documented.
Progress on Jhoni Kumar Roy was appointed as a Director was appointed as a Director on 22 Apr 2022 & has been associated with this company since 3 years 7 months . was documented.
The CIN of Lucevida Pharmaceuticals Private Limited is U51909WB2014PTC203886.
Lucevida Pharmaceuticals Private Limited is headquartered at 6 Buddha Deb Bose Road Ashrampara P.S. Siliguri, Siliguri, West Bengal, 734001.
Lucevida Pharmaceuticals Private Limited was incorporated on 28 October 2014.
The current directors of Lucevida Pharmaceuticals Private Limited are
The primary industry of Lucevida Pharmaceuticals Private Limited is Manufacturing.
Lucevida Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lucevida Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.41 M.
The compliance status of Lucevida Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX